Baker Hughes Co (BKR) - Form 8-K Summary
Business Context and Reporting Period
Date of Report: July 28, 2025
Company: Baker Hughes Company
Event: Entry into a Material Definitive Agreement to acquire Chart Industries, Inc. ("Chart").
On July 28, 2025, Baker Hughes, through its subsidiary Tango Merger Sub, Inc., entered into an Agreement and Plan of Merger to acquire Chart. Upon closing, Chart will become an indirect wholly-owned subsidiary of Baker Hughes. The transaction is approved by the boards of both companies.
Key Financial Metrics and Transaction Terms
Consideration: $210.00 in cash per share of Chart Common Stock.
Financing: Baker Hughes secured a $14.9 billion senior unsecured 364-day bridge loan facility from Goldman Sachs and Morgan Stanley to fund the acquisition.
Debt Structure: The bridge facility is intended to be replaced by permanent financing (senior unsecured debt securities and term loans) prior to closing.
Transaction Fees:
- Chart Termination Fee: $250 million payable by Chart to Baker Hughes under specified termination scenarios.
- Baker Hughes Termination Fee: $500 million payable by Baker Hughes to Chart if the deal fails due to legal restraints or regulatory approval failures.
- Flowserve Payment: Baker Hughes agreed to pay $258 million ($250 million fee + $8 million expenses) to Flowserve Corporation regarding a terminated prior agreement. Chart must reimburse Baker Hughes for this amount if the Merger Agreement is terminated under specified circumstances.
Note: This filing is a Current Report (8-K) and does not contain Baker Hughes' or Chart's quarterly revenue, profit, cash flow, or margin data. Investors should refer to the most recent 10-Q or 10-K filings for operational financial metrics.
Material Changes and Conditions
The filing announces a material change in corporate structure via the proposed merger. The transaction is subject to several conditions, including:
- Approval by holders of Chart Common Stock.
- Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and receipt of foreign regulatory approvals.
- Absence of governmental restraints prohibiting the merger.
- Accuracy of representations and warranties and performance of obligations by both parties.
- No material adverse effect on Chart.
The transaction is not subject to any financing condition.
Outlook, Risks, and Contingencies
Timeline: The Merger Agreement includes an "Outside Date" of one year from the agreement date (July 28, 2026), subject to two automatic six-month extensions if regulatory conditions are not met.
Termination Rights:
- Either party may terminate if the merger is not consummated by the Outside Date.
- Chart may terminate to accept a "Superior Proposal."
- Baker Hughes may terminate if the Chart Board changes its recommendation.
Risks: The filing highlights risks regarding the ability to consummate the transaction, obtain regulatory approvals, finance the deal, service the substantial new indebtedness, and achieve expected synergies. Integration challenges, customer loss, and business disruption are also noted as potential risks.
Investor Verification Checklist
- Regulatory Approval Status: Monitor progress on antitrust clearances (Hart-Scott-Rodino and foreign jurisdictions) as a primary condition to closing.
- Shareholder Vote: Verify the outcome of the Chart stockholder vote required to approve the Merger Agreement.
- Financing Execution: Confirm the conversion of the $14.9 billion bridge facility into permanent debt financing prior to closing.
- Termination Fee Exposure: Assess the impact of the $500 million potential termination fee payable by Baker Hughes and the $258 million Flowserve payment obligation on liquidity.
- Integration Plan: Review the attached Investor Presentation (Exhibit 99.2) for details on expected synergies and integration timelines.